13^th World Gastro Summit

Behind every pill or protocol lies a story of chemistry meeting care. Gastrointestinal pharmacotherapy is where science tackles the spectrum of digestive woes—balancing acid, calming inflammation, restoring motility, and eradicating infection. Whether it’s a proton pump inhibitor easing the burn of GERD, or a biologic targeting chronic inflammation, every medication is a tool in a complex therapeutic arsenal. But it’s not just about what we prescribe—it’s about how, when, and for whom. This track explores the evolving landscape of drug development, precision dosing, and integrated treatment strategies that are reshaping GI care. As our understanding deepens, so too does our ability to tailor therapies that heal more effectively, with fewer side effects and greater patient outcomes.

Children aren't just small adults—their digestive systems have their own timelines, sensitivities, and surprises. Paediatric gastroenterology is a dynamic field dedicated to decoding the complex world of childhood gut health. From the discomforts of reflux in newborns to the challenges of managing IBD or celiac disease in teens, this specialty navigates a wide spectrum of conditions with precision and empathy. Specialists in this area bring not only medical expertise but also a deep understanding of developmental biology and family-centered care. Working closely with paediatricians, dietitians, and multidisciplinary teams, they craft care plans that grow with the child. With innovations in imaging, minimally invasive procedures, and personalized treatment approaches, the future of paediatric GI care is both hopeful and transformative.

Modern gastrointestinal care is deeply rooted in endoscopic innovation and surgical precision. Endoscopy allows clinicians to explore the inner workings of the GI tract in real time—identifying issues such as polyps, tumors, and bleeding sites with minimal invasiveness. Surgical interventions complement this by offering solutions for complex conditions through laparoscopic and robot-assisted techniques. Together, these technologies are transforming how we diagnose, treat, and recover from gastrointestinal diseases—reducing risks, shortening hospital stays, and improving patient outcomes.

Celiac disease is a chronic autoimmune disorder in which gluten ingestion prompts an immune attack on the small intestine. This reaction damages the villi, the delicate structures responsible for absorbing essential nutrients. The consequences can be far-reaching—ranging from digestive discomfort and nutrient malabsorption to fatigue, anemia, and growth issues in children. As awareness grows, so does the research into non-dietary treatments, early diagnostics, and genetic predisposition, offering hope for improved quality of life for those affected

Celiac disease is a chronic autoimmune disorder in which gluten ingestion prompts an immune attack on the small intestine. This reaction damages the villi, the delicate structures responsible for absorbing essential nutrients. The consequences can be far-reaching—ranging from digestive discomfort and nutrient malabsorption to fatigue, anemia, and growth issues in children. As awareness grows, so does the research into non-dietary treatments, early diagnostics, and genetic predisposition, offering hope for improved quality of life for those affected

This track focuses on the critical intersection of abdominal health and primary care medicine, where early detection and continuous management converge. From common gastrointestinal concerns like irritable bowel syndrome and abdominal discomfort to more complex digestive conditions, this field requires an integrated approach. Primary care physicians serve as the keystones—conducting initial diagnoses, prescribing treatments, and connecting patients to specialists when needed. Emphasizing holistic care, preventive screenings, and patient-centered management, this area plays a vital role in maintaining overall health and wellness.

Microbiota represent the vast and dynamic population of microorganisms—bacteria, viruses, fungi, and more—that reside in various environments including the human body, soil, air, and aquatic systems. Within the human body, the gut microbiota is especially significant, acting as a hidden regulator of digestion, immunity, metabolism, and even brain function. A disrupted microbial balance, or dysbiosis, has been increasingly associated with chronic illnesses such as obesity, IBD, and neurodegenerative disorders like Alzheimer’s disease. This evolving field is unlocking new opportunities for microbiome-targeted therapies, paving the way for personalized healthcare strategies.

This track highlights diseases impacting the pancreas and bile ducts. Pancreatitis, or inflammation of the pancreas, may be acute or chronic, and is frequently triggered by gallstones or excessive alcohol use. Symptoms often include severe abdominal pain, nausea, and vomiting. Biliary disorders—such as gallstones, bile duct strictures, and cholangitis—can cause jaundice, digestive disturbances, and abdominal discomfort. Treatment approaches vary depending on the condition and may include medical management, dietary changes, or procedures like cholecystectomy or ERCP (Endoscopic Retrograde Cholangiopancreatography). Prompt diagnosis and intervention are essential to improving outcomes and preventing complications.

Gastroenterology focuses on the diagnosis and treatment of disorders affecting the digestive system, including the stomach, intestines, liver, pancreas, and gallbladder. Specialists in this field manage conditions ranging from acid reflux and IBS to Crohn’s disease and liver cirrhosis.

Relevant Associations:

American Gastroenterological Association

Canadian Society of Gastroenterology Nurses and Associates

European Society of Gastroenterology and Endoscopy Nurses

British Society of Pediatric Gastroenterology

Gastroenterological Society of Australia

Philippine Society of Gastroenterology

Diseases of the small intestine and colon span a range of inflammatory, infectious, and neoplastic conditions. Notable among these are inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, as well as colorectal cancer, diverticulitis, and irritable bowel syndrome (IBS). Diagnostic tools such as colonoscopy, capsule endoscopy, and cross-sectional imaging aid in early and accurate identification. Management strategies are multifaceted—ranging from dietary modifications and pharmacologic therapy to surgical intervention for refractory cases. Advances in personalized medicine and biologic therapies are reshaping the landscape of small bowel and colonic disease treatment, improving patient quality of life and disease outcomes.

Diseases of the small intestine and colon span a range of inflammatory, infectious, and neoplastic conditions. Notable among these are inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, as well as colorectal cancer, diverticulitis, and irritable bowel syndrome (IBS). Diagnostic tools such as colonoscopy, capsule endoscopy, and cross-sectional imaging aid in early and accurate identification. Management strategies are multifaceted—ranging from dietary modifications and pharmacologic therapy to surgical intervention for refractory cases. Advances in personalized medicine and biologic therapies are reshaping the landscape of small bowel and colonic disease treatment, improving patient quality of life and disease outcomes.

The COVID-19 pandemic brought unprecedented changes to gastroenterology practices globally. Elective and non-urgent endoscopic procedures were deferred, straining diagnostic workflows and causing delays in treatment. The rapid adoption of telemedicine provided a partial solution for continued care, though challenges remain in evaluating complex GI conditions remotely. Practices were restructured to prioritize safety, with heightened infection control protocols, including strict hygiene practices and the use of personal protective equipment (PPE). Despite the disruption, the pandemic acted as a catalyst for innovation—accelerating digital integration and prompting the reevaluation of traditional care models in gastroenterology.

Gastrointestinal pathology encompasses a broad spectrum of diseases affecting the digestive tract, including both inflammatory and neoplastic conditions. Disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, celiac disease, Crohn’s disease, ulcerative colitis, pancreatitis, cirrhosis, and GI cancers are among the most prevalent. Diagnostic protocols typically involve endoscopy, advanced imaging techniques, and histopathological evaluation of biopsies. Tailored treatment regimens may include pharmacotherapy, dietary adjustments, surgical interventions, or integrative therapies, depending on the specific pathology. Timely diagnosis and a patient-centered approach are pivotal for effective management and long-term disease control.

Gastrointestinal (GI) cancers represent a diverse group of malignancies that affect organs within the digestive system, including the esophagus, stomach, liver, pancreas, colon, and rectum. These cancers are a major contributor to global cancer-related morbidity and mortality. Due to their varied etiologies and progression patterns, GI cancers require individualized treatment strategies. Current therapeutic approaches—such as surgical resection, chemotherapy, radiotherapy, immunotherapy, and molecularly targeted agents—are often combined to enhance outcomes. A multidisciplinary framework involving oncologists, gastroenterologists, surgeons, radiologists, and pathologists is essential for personalized treatment planning and improved patient survival.

Gastrointestinal (GI) cancers encompass malignancies affecting the digestive tract, including the esophagus, stomach, liver, pancreas, colon, and rectum. These cancers present a significant global health burden, with diverse etiologist and varying prognoses. Treatment modalities include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy, often used in combination for optimal efficacy. Multidisciplinary approaches involving oncologists, surgeons, gastroenterologists, and other specialists are crucial for comprehensive care and improved patient outcomes.

Hepatology focuses on the diagnosis and treatment of liver diseases, including hepatitis, cirrhosis, fatty liver, liver cancer, and autoimmune disorders. Hepatologists use tools like blood tests, imaging, and biopsies to assess liver health and guide care. Treatments may include medication, lifestyle changes, or liver transplantation. As liver conditions become increasingly common, this field plays a critical role in early detection and effective management.

Relevant Associations:

Canadian Association of Gastroenterology

American Neurogastroenterology and Motility Society

European Society of Gastrointestinal Endoscopy

ESPGHAN

Gastroenterological Association of Thailand (GAT)